U.S.

- Europe

- Japan

- China

- Other Foreign Countries

Outside U.S.

Total Revenue

56a806db86a60a1a66e71d70e87486501f356350d4d9be684b5b9f2d8b8f9734

25315fa7e5ad88faa824a8ef12daa8eaffe32a6ebfafed077b4547a573d13c41

Net income [USD, millions]

Depreciation and amortization [USD, millions]

Change in deferred income taxes [USD, millions]

Stock-based compensation expense [USD, millions]

Net investment (gains) losses [USD, millions]

Acquired in-process research and development [USD, millions]

Other changes in operating assets and liabilities, net of acquisitions and divestitures [USD, millions]

Other operating activities, net [USD, millions]

Net Cash Provided by Operating Activities [USD, millions]

Purchases of property and equipment [USD, millions]

Proceeds from sales of and distributions from noncurrent investments [USD, millions]

Purchases of noncurrent investments [USD, millions]

Purchases of in-process research and development [USD, millions]

Other investing activities, net [USD, millions]

Net Cash Used for Investing Activities [USD, millions]

Dividends paid [USD, millions]

Net change in short-term borrowings [USD, millions]

Proceeds from issuance of long-term debt [USD, millions]

Purchases of common stock [USD, millions]

Other financing activities, net [USD, millions]

Net Cash Provided by (Used for) Financing Activities [USD, millions]

Effect of exchange rate changes on cash and cash equivalents [USD, millions]

Net increase (decrease) in cash and cash equivalents [USD, millions]

Cash and cash equivalents at January 1 [USD, millions]

Cash and Cash Equivalents at March 31 [USD, millions]

f8b47f845e9fd679b1558d9a6baa2653b9e5449c11999d78d3d3a63fced98bcf

a2c931e34aa31c2a864044e659a1e913ddcf2e920e6fa657292b357c3d72a289

Revenue (USD, millions)

Cost of Sales (USD, millions)

Research and Development Expenses (USD, millions)

Marketing, Selling, and Administrative Expenses (USD, millions)

Acquired In-Process Research and Development (USD, millions)

Asset Impairment, Restructuring, and Other Special Charges (USD, millions)

Other-Net, (Income) Expense (USD, millions)

Income Before Income Taxes (USD, millions)

Income Taxes (USD, millions)

Net Income (Loss) (USD, millions)

Diluted Earnings (Loss) per Share (USD)

Gross Margin (USD, millions)

Gross Margin as a Percent of Revenue (%)

Effective Tax Rate (%)

ad0b3d35dcdb4ddf04c6d115739e25a5f613a85b78d9fb6b4e7b54b5f822cd26

Eli Lilly and Co (LLY)

Financials